Premium
Asian investment firm PAG plans to acquire a significant minority stake in specialty injectables company RK Pharma Inc. and its subsidiaries, according to people familiar with the deal. Besides secondary shares sales, transaction includes primary funding that will aid the company to expand business. The total deal size is around $200 million, ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
